153 related articles for article (PubMed ID: 22347255)
21. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.
Bohne W; Heesemann J; Gross U
Infect Immun; 1994 May; 62(5):1761-7. PubMed ID: 8168938
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of susceptibility of chicken macrophages to infection with Toxoplasma gondii of type II and III strains.
Malkwitz I; Berndt A; Daugschies A; Bangoura B
Exp Parasitol; 2018 Apr; 187():22-29. PubMed ID: 29518451
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effects of cold stress on mice infected intraperitoneally with a 50% lethal dose of Toxoplasma gondii.
Aviles H; Monroy FP
Neuroimmunomodulation; 2001; 9(1):6-12. PubMed ID: 11435747
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1.
Mahmoud ME; Ui F; Salman D; Nishimura M; Nishikawa Y
Cell Microbiol; 2015 Jul; 17(7):1069-83. PubMed ID: 25628099
[TBL] [Abstract][Full Text] [Related]
25. Toxoplasma gondii infection of activated J774-A1 macrophages causes inducible nitric oxide synthase degradation by the proteasome pathway.
Padrão Jda C; Cabral GR; da Silva Mde F; Seabra SH; DaMatta RA
Parasitol Int; 2014 Oct; 63(5):659-63. PubMed ID: 24845536
[TBL] [Abstract][Full Text] [Related]
26. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism.
Chao CC; Anderson WR; Hu S; Gekker G; Martella A; Peterson PK
Clin Immunol Immunopathol; 1993 May; 67(2):178-83. PubMed ID: 8519093
[TBL] [Abstract][Full Text] [Related]
27. [The role of L-arginine and L-citrulline in activated macrophage against Toxoplasma gondii infection in vitro].
Zheng C; Lin J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(5):326-30. PubMed ID: 12078267
[TBL] [Abstract][Full Text] [Related]
28. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.
Sher A; Oswald IP; Hieny S; Gazzinelli RT
J Immunol; 1993 May; 150(9):3982-9. PubMed ID: 8473745
[TBL] [Abstract][Full Text] [Related]
29. Use of mouse macrophage cell lines for in vitro propagation of Toxoplasma gondii RH tachyzoites.
Chamberland S; Current WL
Proc Soc Exp Biol Med; 1991 Jun; 197(2):150-7. PubMed ID: 2031052
[TBL] [Abstract][Full Text] [Related]
30. In contrast to Toxoplasma gondii, Neospora caninum tachyzoites did not sustain multiplication in vitro at increased incubation temperatures.
Rezende-Gondim MM; da Silva AV; Schares G; Gondim LF
Vet Parasitol; 2017 Jan; 234():19-24. PubMed ID: 28115178
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide stimulates early egress of Toxoplasma gondii tachyzoites from Human foreskin fibroblast cells.
Yan X; Ji Y; Liu X; Suo X
Parasit Vectors; 2015 Aug; 8():420. PubMed ID: 26264067
[TBL] [Abstract][Full Text] [Related]
32. Biostatic activity of Coix lacryma seed extract on Toxoplasma gondii in macrophages.
Soh CT; Kim SH; Kim KY; Park H; Chung HT; Kim TU; Jeon SM; Han YB
Korean J Parasitol; 1996 Sep; 34(3):197-206. PubMed ID: 8843696
[TBL] [Abstract][Full Text] [Related]
33. The production of a 70 kDa heat shock protein by Toxoplasma gondii RH strain in immunocompromised mice.
Miller CM; Akratos C; Johnson AM; Smith NC
Int J Parasitol; 2000 Dec; 30(14):1467-73. PubMed ID: 11428337
[TBL] [Abstract][Full Text] [Related]
34. In vitro effect of TNF-alpha and IFN-gamma in retinal cell infection with Toxoplasma gondii.
Delair E; Creuzet C; Dupouy-Camet J; Roisin MP
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1754-60. PubMed ID: 19321794
[TBL] [Abstract][Full Text] [Related]
35. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
[TBL] [Abstract][Full Text] [Related]
36. Anti-
Teimouri A; Azami SJ; Keshavarz H; Esmaeili F; Alimi R; Mavi SA; Shojaee S
Int J Nanomedicine; 2018; 13():1341-1351. PubMed ID: 29563791
[TBL] [Abstract][Full Text] [Related]
37.
Zaki L; Ghaffarifar F; Sharifi Z; Horton J; Sadraei J
EXCLI J; 2020; 19():514-527. PubMed ID: 32398975
[TBL] [Abstract][Full Text] [Related]
38. Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages.
Moreira-Souza AC; Marinho Y; Correa G; Santoro GF; Coutinho CM; Vommaro RC; Coutinho-Silva R
PLoS One; 2015; 10(7):e0133502. PubMed ID: 26192447
[TBL] [Abstract][Full Text] [Related]
39. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
Kang H; Remington JS; Suzuki Y
J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between the dose and the anti-Toxoplasma effect of activated mouse macrophages induced by IFN-gamma and the synergism between IFN-gamma and TNF-alpha].
Zhang A; Yang H; Yang Y; Qian Z
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(6):436-40. PubMed ID: 12078289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
